Monday, January 16, 2012

nasdaq stock to watch january 17 2012

nasdaq stock to watch jan 17 2012 : according www.InvestorIdeas.com, a global investor research portal for independent investors, reports on the top five percentage gainers on the NASDAQ for Friday January 13th. The NASDAQ closed at 2710.67, down 14.03 or 0.51%. Markets are closed Monday, January 16th.

ZAGG Inc (NASDAQ:ZAGG) closed up at $ 8.10, up 0.97 13.60% on volume of 3,438,059 and continued its gains in after hours trading. On Wednesday last week the Company reported it introduced a new premium version of their patented film in the award-winning invisibleSHIELD® line at International CES 2012, called the invisibleSHIELD HD™. The new line offers industry-leading clarity and finish in a protective film, and is available online at ZAGG.com beginning January 12, as well as at ZAGG retail outlets, and through a select retail partner.

Idenix Pharmaceuticals, Inc (NASDAQ:IDIX) ended at $ 14.42, up 1.71 13.45%on 6,478,749 shares. The stock was up another 1.6% after hours. On January 9 th, the Company reported the advancement of its hepatitis C virus (HCV) development pipeline.

BroadVision, Inc. (NASDAQ:BVSN) finished the day at $ 17.59, up 2.04 13.12% on 300,415 shares, with a slight downtrend after hours. The Company announced that it will release its fourth quarter 2011 financial results on Thursday, January 26 at approximately 1:30PM Pacific Standard Time (PST).

Renewable energy stock, Mission NewEnergy Limited (NASDAQ:MNEL) closed up at $ 2.54, up 0.29 12.89%on 16,987 shares.

Array BioPharma Inc. (NASDAQ:ARRY) ended trading at $ 2.38, up 0.25 11.74% on volume of 832,017.

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming. for more information visit InvestorIdeas.com
For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post:

No comments:

Post a Comment